MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Cash Flow Overview
Change in Cash
$259,784K
Free Cash flow
$1,649,544K
Unit: Thousand (K) dollars
Positive Cash Flow Breakdown
Net income
Accounts payable, accrued expens...
Stock-based compensation costs (...
Others
Negative Cash Flow Breakdown
Purchases of treasury stock
Business acquisitions, net of ca...
Dividends paid
Others
Subscribe for Financial Insights
Page 1
Annual
123
Page 1
Cash Flow
2026-06-30
2025-06-30
2024-06-30
2023-06-30
Net income
1,523,293
1,400,723
1,020,951
897,556
Depreciation and amortization
201,342
198,473
176,870
165,156
Amortization of right-of-use assets
42,810
37,338
39,339
32,406
Stock-based compensation costs (note 10)
104,348
91,661
80,184
71,142
(gain) loss attributable to equity method investments, net of dividends received (note 6)
2,382
3,644
-1,848
-
Loss attributable to equity method investments, net of dividends received (note 5)
-
-
-
10,138
(gain) loss on equity investments (note 6)
-15,014
-
-
-
(gain) loss on equity investments (note 5)
-
-
-
-9,922
(gain) loss on equity investments (note 6)
-
-10,299
-4,045
-
Gain on previously held equity investment (note 6)
4,353
-
-
-
Restructuring expenses (note 18)
-
-
-
9,177
Restructuring expenses (note 17)
0
0
33,239
-
Gain on insurance recoveries
-
0
0
20,227
Accounts receivable
96,778
76,684
134,278
106,511
Inventories
9,920
80,165
-172,203
248,833
Prepaid expenses, net deferred income taxes and other current assets
140,260
-82,629
115,213
138,125
Accounts payable, accrued expenses and other
172,715
90,958
122,072
31,342
Net cash provided by (used in) operating activities
1,805,829
1,751,588
1,401,260
693,299
Purchases of property, plant and equipment
156,285
89,865
99,460
119,672
Patent registration costs
18,670
-
-
-
Purchases of intangible assets
2,218
10,777
15,396
14,328
Business acquisitions, net of cash acquired
350,724
139,248
133,464
1,012,749
Purchases of investments (note 6)
28,536
6,416
12,765
32,229
Proceeds from exits of investments (note 6)
2,752
4,628
1,000
3,937
Proceeds (payments) on maturity of foreign currency contracts
-8,482
-41,633
9,699
-15,196
Net cash provided by (used in) investing activities
-545,199
-200,045
-269,784
-1,159,845
Proceeds from issuance of common stock, net
74,503
74,439
53,094
49,142
Taxes paid related to net share settlement of equity awards
21,833
18,077
8,757
30,631
Purchases of treasury stock
700,037
300,025
150,011
-
Payments of business combination contingent consideration
0
855
1,293
2,361
Acquisition of consolidated subsidiary
0
10,855
-
-
Proceeds from borrowings, net of borrowing costs
0
0
105,000
1,070,000
Repayment of borrowings
10,000
40,000
835,000
405,000
Dividends paid
349,662
310,880
282,320
258,276
Net cash provided by (used in) financing activities
-1,007,029
-606,253
-1,119,287
422,874
Effect of exchange rate changes on cash
6,183
25,799
-1,719
-2,147
Net increase (decrease) in cash and cash equivalents
259,784
971,089
10,470
-45,819
Cash and cash equivalents at beginning of period
1,209,450
238,361
227,891
273,710
Cash and cash equivalents at end of period
1,469,234
1,209,450
238,361
227,891
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS).
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Cash Flow
Net income
$1,523,293K
(8.75%↑ Y/Y)
Depreciation and
amortization
$201,342K
(1.45%↑ Y/Y)
Accounts payable,
accrued expenses and...
$172,715K
(89.88%↑ Y/Y)
Stock-based compensation
costs (note 10)
$104,348K
(13.84%↑ Y/Y)
Amortization of right-of-use
assets
$42,810K
(14.66%↑ Y/Y)
(gain) loss on equity
investments (note 6)
-$15,014K
(-45.78%↓ Y/Y)
Net cash provided by
(used in) operating...
$1,805,829K
(3.10%↑ Y/Y)
Effect of exchange rate
changes on cash
$6,183K
(-76.03%↓ Y/Y)
Canceled cashflow
$253,693K
Net increase
(decrease) in cash and cash...
$259,784K
(-73.25%↓ Y/Y)
Canceled cashflow
$1,552,228K
Prepaid expenses, net
deferred income taxes and...
$140,260K
(269.75%↑ Y/Y)
Accounts receivable
$96,778K
(26.20%↑ Y/Y)
Inventories
$9,920K
(-87.63%↓ Y/Y)
Gain on previously
held equity...
$4,353K
(gain) loss
attributable to equity method...
$2,382K
(-34.63%↓ Y/Y)
Proceeds from issuance of
common stock, net
$74,503K
(0.09%↑ Y/Y)
Proceeds (payments) on
maturity of foreign...
-$8,482K
(79.63%↑ Y/Y)
Proceeds from exits of
investments (note 6)
$2,752K
(-40.54%↓ Y/Y)
Net cash provided by
(used in) financing...
-$1,007,029K
(-66.11%↓ Y/Y)
Net cash provided by
(used in) investing...
-$545,199K
(-172.54%↓ Y/Y)
Canceled cashflow
$74,503K
Canceled cashflow
$11,234K
Purchases of treasury
stock
$700,037K
(133.33%↑ Y/Y)
Dividends paid
$349,662K
(12.47%↑ Y/Y)
Business acquisitions,
net of cash acquired
$350,724K
(151.87%↑ Y/Y)
Purchases of property,
plant and equipment
$156,285K
(73.91%↑ Y/Y)
Purchases of investments
(note 6)
$28,536K
(344.76%↑ Y/Y)
Patent registration
costs
$18,670K
Taxes paid related to
net share...
$21,833K
(20.78%↑ Y/Y)
Repayment of borrowings
$10,000K
(-75.00%↓ Y/Y)
Purchases of intangible
assets
$2,218K
(-79.42%↓ Y/Y)
Buy us a coffee
RESMED INC (RSMDF)
RESMED INC (RSMDF)